Endeavor Power Corporation Outlines Its New Target Market, Its Size and Projected Growth
Published: Jan 09, 2013
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Endeavor Power Corporation (“Endeavor Power” or the “Company”) (OTCQB: EDVP) provides an outline of its new target market in the Point-of-Care In Vitro diagnostics market. The point-of-care testing (“POCT”) market has been predicted to reach a total market value of $34.6 billion by 2021, according to a recent report published by Kalorama Information. With the ability to help reduce healthcare costs while simultaneously improving patient care, POCT represent a significant and growing share of the global in vitro diagnostics (“IVD”) market, according to the marketing research firm Kalorama. In 2010 the value of the POCT market was $13.4 billion and grew to $13.8 billion in 2011. Over the five-year period to 2016 the market is expected to experience a compound annual growth rate (CAGR) of 3.7%, to further increase its value to $16.5 billion.